NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC)

CUSIP: 64130M209

Q1 2022 13F Holders as of 31 Mar 2022

Holder snapshot 6 signals
Share change
-1,239,077
SEC-reported price per share
$1.10
Number of holders
8
Value change
-$2,285,922
Number of buys
4
Number of sells
8
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
8,477,622

Security key

64130M209

Report period

Q1 2022

Institutions

8

Top holders

8

Ownership snapshot

Top reported holders of NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Stonepine Capital Managem...
Disclosed value leader
AWM Investment Company, Inc.
Comparable rows
13/14
Latest evidence
31 Dec 2021
13F Lead comparable stake: 5.9% 1 rows are not safely comparable across share classes. Showing 1-6 of 14 holder rows.

Quick read

Stonepine Capital Management, LLC leads the comparable SEC ownership view at 5.9%.

13 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Stonepine Capital Management, LLC's linked filing trail.
Comparable ownership Top 5
Stonepine Capital Management, LLC 5.9%
AIGH Capital Management LLC 5.6%
Bleichroeder LP 4.4%
VANGUARD GROUP INC 2.6%
Worth Venture Partners, LLC 1.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 14 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Stonepine Capital Management, LLC
13F
Company
13F
5.9%
$967,000
498,354 shares
31 Dec 2021
AIGH Capital Management LLC
13F
Company
13F
5.6%
$921,000
475,000 shares
31 Dec 2021
Bleichroeder LP
13F
Company
13F
4.4%
$728,000
375,000 shares
31 Dec 2021
VANGUARD GROUP INC
13F
Company
13F
2.6%
$421,000
217,232 shares
31 Dec 2021
Worth Venture Partners, LLC
13F
Company
13F
1.3%
$211,000
108,964 shares
31 Dec 2021
Eidelman Virant Capital
13F
Company
13F
0.88%
$146,000
75,000 shares
31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
8
Shares
707,048
Rows available
8
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders
12
Q1 2022 holders
8
Holder diff
-4
Investor Q4 2021 Shares Q1 2022 Shares Share Diff Share Chg % Q4 2021 value Q1 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .